Tilray Italia
About Tilray Italia
Italian subsidiary of Canadian LP Tilray, supplying GMP-grade medical cannabis products to Italian pharmacies through the national health system.
Key Facts
- 1One of the first international LPs authorised to supply medical cannabis to Italy's SSN health system
- 2Products dispensed through hospital and community pharmacies with a medical prescription
Latest News
Tilray Accelerates Medical Cannabis Expansion Despite Sector Headwinds
TLRY pushes international medical platform growth as cannabis stocks face regulatory uncertainty and market volatility
Tilray's Panama Push Tests International Cannabis Expansion Strategy
TLRY explores Central American operations as cannabis companies seek growth beyond saturated North American markets amid regulatory headwinds.
Tilray Stock Eyes Inflection Point as Cannabis Markets Shift
TLRY approaches critical juncture amid evolving regulatory landscape and operational restructuring efforts across North American cannabis markets.
TLRY Diversifies Beyond Cannabis With Craft Beverage Expansion
Tilray Brands leverages dual-market strategy combining cannabis operations with craft beverage acquisitions to drive revenue growth and market expansion.
Tilray Positioned for US Cannabis Rescheduling Windfall
TLRY stock could surge as federal rescheduling opens massive US market opportunities for the Canadian cannabis giant's established operations.
Frequently Asked Questions
How do patients access Tilray products in Italy?
Patients need a prescription from an authorised physician; products are dispensed at licensed pharmacies.
Is Tilray Italia publicly traded?
The parent company Tilray Brands trades on NASDAQ under TLRY; the Italian subsidiary is not separately listed.
More Cannabis Companies in Rome
Cannabis Laws
Products
- Dried medical cannabis
- Cannabis oil extracts
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Rome, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY